We found that tumor suppression induced by the Arf1 inhibitor treatment was significantly abolished in the PCYT2-deficient CT26 allografts (Fig. 6g and h, Supplementary Fig. S6d), while the body weights of mice showed no difference (Supplementary Fig. S6e). This evidence concerns the gene DDX53 and neoplasm.